ADVB

$4.55

Post-MarketAs of Mar 17, 8:00 PM UTC

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

TipRanks
Dec 31, 2025

Advanced Biomed sells Hong Kong subsidiary for $23,000

Advanced Biomed (ADVB) entered into an agreement with an unrelated third party, Wei Ha Hui, pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed Limited, a Hong Kong company and a wholly owned subsidiary of the Company, for an aggregate purchase price of $23,000 based on a valuation report commissioned by the Company, subject to the terms and conditions set forth in the Agreement. All intellectual property owned by the Hong Kong subsidiary, in

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.